Why the study?
Primary adrenal lymphoma is a rare tumor, and the study aimed to demonstrate its histopathological features at two tertiary hospitals.
Population
7 patients with primary adrenal lymphoma
Design
Retrospective study at two tertiary hospitals
Key result
Primary adrenal lymphoma is a rare disease of the elderly, predominantly diffuse large B-cell lymphoma, with a poor prognosis demonstrated by 1-year and 2-year overall survival rates of 50% and 33%, respectively.
Authors
Loading...
Alerts clinicians to include primary adrenal lymphoma in elderly adrenal mass differentials; leaves optimal therapy open pending prospective data.
Observational (n=7)
Yes
Primary adrenal lymphoma is a rare disease of the elderly, most commonly diffuse large B-cell lymphoma, and is associated with a poor prognosis.
Jaudah Al‐Maghrabi (2023) conducted an observational in Primary Adrenal Lymphoma (n=7). Primary Adrenal Lymphoma was evaluated on 1-year and 2-year overall survival rates. Primary adrenal lymphoma is a rare disease of the elderly, predominantly diffuse large B-cell lymphoma, with a poor prognosis demonstrated by 1-year and 2-year overall survival rates of 50% and 33%, respectively.